The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Moexipril an angiotensin converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure
Global Moexipril market is projected to reach US$ 128.9 million in 2029, increasing from US$ 102 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Moexipril market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Moexipril market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Shermco
Avet Pharmaceuticals
Chartwell Pharmaceuticals
Glenmark Pharmaceuticals
Viatris
Teva Pharmaceuticals
UCB Pharm
Emcure Pharmaceuticals
Segment by Type
7.5Mg
12.5Mg
15Mg
Other
Segment by Application
Hypertension
Heart failure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Moexipril report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Moexipril an angiotensin converting enzyme inhibitor (ACE inhibitor) used for the treatment of hypertension and congestive heart failure
Global Moexipril market is projected to reach US$ 128.9 million in 2029, increasing from US$ 102 million in 2022, with the CAGR of 3.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Moexipril market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Moexipril market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Shermco
Avet Pharmaceuticals
Chartwell Pharmaceuticals
Glenmark Pharmaceuticals
Viatris
Teva Pharmaceuticals
UCB Pharm
Emcure Pharmaceuticals
Segment by Type
7.5Mg
12.5Mg
15Mg
Other
Segment by Application
Hypertension
Heart failure
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Moexipril report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Moexipril Market Overview
1.1 Product Overview and Scope of Moexipril
1.2 Moexipril Segment by Type
1.2.1 Global Moexipril Market Value Comparison by Type (2023-2029)
1.2.2 7.5Mg
1.2.3 12.5Mg
1.2.4 15Mg
1.2.5 Other
1.3 Moexipril Segment by Application
1.3.1 Global Moexipril Market Value by Application: (2023-2029)
1.3.2 Hypertension
1.3.3 Heart failure
1.4 Global Moexipril Market Size Estimates and Forecasts
1.4.1 Global Moexipril Revenue 2018-2029
1.4.2 Global Moexipril Sales 2018-2029
1.4.3 Global Moexipril Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Moexipril Market Competition by Manufacturers
2.1 Global Moexipril Sales Market Share by Manufacturers (2018-2023)
2.2 Global Moexipril Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Moexipril Average Price by Manufacturers (2018-2023)
2.4 Global Moexipril Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Moexipril, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Moexipril, Product Type & Application
2.7 Moexipril Market Competitive Situation and Trends
2.7.1 Moexipril Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Moexipril Players Market Share by Revenue
2.7.3 Global Moexipril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Moexipril Retrospective Market Scenario by Region
3.1 Global Moexipril Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Moexipril Global Moexipril Sales by Region: 2018-2029
3.2.1 Global Moexipril Sales by Region: 2018-2023
3.2.2 Global Moexipril Sales by Region: 2024-2029
3.3 Global Moexipril Global Moexipril Revenue by Region: 2018-2029
3.3.1 Global Moexipril Revenue by Region: 2018-2023
3.3.2 Global Moexipril Revenue by Region: 2024-2029
3.4 North America Moexipril Market Facts & Figures by Country
3.4.1 North America Moexipril Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Moexipril Sales by Country (2018-2029)
3.4.3 North America Moexipril Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Moexipril Market Facts & Figures by Country
3.5.1 Europe Moexipril Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Moexipril Sales by Country (2018-2029)
3.5.3 Europe Moexipril Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Moexipril Market Facts & Figures by Country
3.6.1 Asia Pacific Moexipril Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Moexipril Sales by Country (2018-2029)
3.6.3 Asia Pacific Moexipril Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Moexipril Market Facts & Figures by Country
3.7.1 Latin America Moexipril Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Moexipril Sales by Country (2018-2029)
3.7.3 Latin America Moexipril Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Moexipril Market Facts & Figures by Country
3.8.1 Middle East and Africa Moexipril Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Moexipril Sales by Country (2018-2029)
3.8.3 Middle East and Africa Moexipril Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Moexipril Sales by Type (2018-2029)
4.1.1 Global Moexipril Sales by Type (2018-2023)
4.1.2 Global Moexipril Sales by Type (2024-2029)
4.1.3 Global Moexipril Sales Market Share by Type (2018-2029)
4.2 Global Moexipril Revenue by Type (2018-2029)
4.2.1 Global Moexipril Revenue by Type (2018-2023)
4.2.2 Global Moexipril Revenue by Type (2024-2029)
4.2.3 Global Moexipril Revenue Market Share by Type (2018-2029)
4.3 Global Moexipril Price by Type (2018-2029)
5 Segment by Application
5.1 Global Moexipril Sales by Application (2018-2029)
5.1.1 Global Moexipril Sales by Application (2018-2023)
5.1.2 Global Moexipril Sales by Application (2024-2029)
5.1.3 Global Moexipril Sales Market Share by Application (2018-2029)
5.2 Global Moexipril Revenue by Application (2018-2029)
5.2.1 Global Moexipril Revenue by Application (2018-2023)
5.2.2 Global Moexipril Revenue by Application (2024-2029)
5.2.3 Global Moexipril Revenue Market Share by Application (2018-2029)
5.3 Global Moexipril Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Moexipril Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Shermco
6.2.1 Shermco Corporation Information
6.2.2 Shermco Description and Business Overview
6.2.3 Shermco Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Shermco Moexipril Product Portfolio
6.2.5 Shermco Recent Developments/Updates
6.3 Avet Pharmaceuticals
6.3.1 Avet Pharmaceuticals Corporation Information
6.3.2 Avet Pharmaceuticals Description and Business Overview
6.3.3 Avet Pharmaceuticals Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Avet Pharmaceuticals Moexipril Product Portfolio
6.3.5 Avet Pharmaceuticals Recent Developments/Updates
6.4 Chartwell Pharmaceuticals
6.4.1 Chartwell Pharmaceuticals Corporation Information
6.4.2 Chartwell Pharmaceuticals Description and Business Overview
6.4.3 Chartwell Pharmaceuticals Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Chartwell Pharmaceuticals Moexipril Product Portfolio
6.4.5 Chartwell Pharmaceuticals Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Corporation Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Glenmark Pharmaceuticals Moexipril Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Viatris Moexipril Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Corporation Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Pharmaceuticals Moexipril Product Portfolio
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.8 UCB Pharm
6.8.1 UCB Pharm Corporation Information
6.8.2 UCB Pharm Description and Business Overview
6.8.3 UCB Pharm Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.8.4 UCB Pharm Moexipril Product Portfolio
6.8.5 UCB Pharm Recent Developments/Updates
6.9 Emcure Pharmaceuticals
6.9.1 Emcure Pharmaceuticals Corporation Information
6.9.2 Emcure Pharmaceuticals Description and Business Overview
6.9.3 Emcure Pharmaceuticals Moexipril Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Emcure Pharmaceuticals Moexipril Product Portfolio
6.9.5 Emcure Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Moexipril Industry Chain Analysis
7.2 Moexipril Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Moexipril Production Mode & Process
7.4 Moexipril Sales and Marketing
7.4.1 Moexipril Sales Channels
7.4.2 Moexipril Distributors
7.5 Moexipril Customers
8 Moexipril Market Dynamics
8.1 Moexipril Industry Trends
8.2 Moexipril Market Drivers
8.3 Moexipril Market Challenges
8.4 Moexipril Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
